Serum miR-155, miR-21, and CA 15.3 for diagnosis and monitoring therapy of breast cancer in females

• मुख्य लेखकों: Khalid O El Khateeb (लेखक), Abdelraouf A Abonar (लेखक), Mosaad M Ibrahim (लेखक), Mohamed I Shalamesh (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Wolters Kluwer Medknow Publications, 2021-01-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Background and Aim Carbohydrate antigen 15.3 (CA 15.3) is the most frequently used tumor marker in breast cancer (BC). MicroRNAs (miRs) can be used to screen, diagnose, evaluate, and follow-up on some cancers. Our research aimed to explore the value of circulating miR-155 and miR-21 for diagnosis an...